Glycosylation defining cancer cell motility and invasiveness, Glycoconjugate Journal, vol.20, issue.1, pp.71-78, 2004. ,
DOI : 10.1023/B:GLYC.0000018019.22070.7d
Signaling in Innate Immunity and Inflammation, Cold Spring Harbor Perspectives in Biology, vol.4, issue.3, p.6049, 2012. ,
DOI : 10.1101/cshperspect.a006049
Posttranslationally modified T cell epitopes: immune recognition and immunotherapy ,
Cell surface glycan???lectin interactions in tumor metastasis, Acta Histochemica, vol.113, issue.6, pp.591-600, 2011. ,
DOI : 10.1016/j.acthis.2011.03.001
Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer, Mini-Reviews in Medicinal Chemistry, vol.6, issue.12, pp.1357-1373, 2006. ,
DOI : 10.2174/138955706778992996
URL : https://hal.archives-ouvertes.fr/pasteur-00166622
Suppression of tumor growth and metastasis in Mgat5-deficient mice, Nat. Med, vol.6, pp.306-312, 2000. ,
Genes that mediate breast cancer metastasis to the brain, Nature, vol.6, issue.7249, pp.1005-1009, 2009. ,
DOI : 10.1038/nature08021
pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen, Biochemical and Biophysical Research Communications, vol.419, issue.1, pp.7-13, 2012. ,
DOI : 10.1016/j.bbrc.2012.01.086
N-Glycans in cancer progression future science group Review Freire & Osinaga postoperative survival in non-small cell lung cancer, Glycobiology Ann. Thorac. Surg, vol.18, issue.665, pp.750-760, 1998. ,
Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer, International Journal of Cancer, vol.261, issue.12, pp.406-412, 1996. ,
DOI : 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.0.CO;2-0
Axis of evil: molecular mechanisms of cancer metastasis, Oncogene, vol.22, issue.42, pp.6524-6536, 2003. ,
DOI : 10.1038/sj.onc.1206757
The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1, International Journal of Oncology, vol.28, issue.1, pp.155-160, 2006. ,
DOI : 10.3892/ijo.28.1.155
Glycodynamics of Mucin Biosynthesis in Gastrointestinal Tumor Cells ,
DOI : 10.1007/978-1-4615-0065-0_11
Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines, Adv. Exp. Med. Biol, vol.491, pp.369-402, 2001. ,
DOI : 10.1007/978-1-4615-1267-7_24
Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients, Cancer, vol.264, issue.9, pp.1960-1966, 1990. ,
DOI : 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer, Cancer Res, vol.49, issue.1, pp.197-204, 1989. ,
Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression, Cancer, vol.178, issue.1, pp.219-227, 1992. ,
DOI : 10.1002/1097-0142(19920101)69:1<219::AID-CNCR2820690136>3.0.CO;2-A
Localization and identification of T-(Gal beta 1?3GalNAc alpha 1-O-R) and T-like antigens in experimental rat bladder cancer, J. Urol, vol.148, issue.4, pp.1279-1284, 1992. ,
Carbohydrate signals in metastasis and prognosis of human carcinomas, Glycobiology, vol.3, issue.4, pp.291-296, 1993. ,
DOI : 10.1093/glycob/3.4.291
Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study, Histochemistry and Cell Biology, vol.213, issue.Suppl 27, pp.197-207, 1996. ,
DOI : 10.1007/BF02484401
T and Tn, general carcinoma autoantigens, Science, vol.224, issue.4654, pp.1198-1206, 1984. ,
DOI : 10.1126/science.6729450
The sweet and sour of cancer: glycans as novel therapeutic targets, Nature Reviews Cancer, vol.532, issue.7, pp.526-542, 2005. ,
DOI : 10.1016/S0300-9084(99)80131-X
Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen, J. Immunol, vol.139, issue.9, pp.3171-3176, 1987. ,
Targeting the GD3 acetylation pathway selectively induces apoptosis in glioblastoma, Neuro-Oncology, vol.13, issue.9, pp.950-960, 2011. ,
DOI : 10.1093/neuonc/nor108
Immunohistological detection of fucosyl- GM1 ganglioside in human lung cancer and normal tissues with monoclonal antibodies, Cancer Res, vol.49, issue.5, pp.1300-1305, 1989. ,
Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1, Cancer Res, vol.46, issue.3, pp.1403-1407, 1986. ,
Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum, Cancer Res, vol.51, issue.11, pp.2879-2884, 1991. ,
Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers, Clin. Cancer Res, vol.4, issue.2, pp.295-302, 1998. ,
Glycan changes: cancer metastasis and anti-cancer vaccines, Journal of Biosciences, vol.51, issue.Suppl.1, pp.665-673, 2010. ,
DOI : 10.1007/s12038-010-0073-8
Cancer immunoediting: from immunosurveillance to tumor escape, Nature Immunology, vol.3, issue.11, pp.991-998, 2002. ,
DOI : 10.1038/ni1102-991
Natural Innate and Adaptive Immunity to Cancer, Annual Review of Immunology, vol.29, issue.1, pp.235-271, 2011. ,
DOI : 10.1146/annurev-immunol-031210-101324
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion, Science, vol.331, issue.6024, pp.1565-1570, 2011. ,
DOI : 10.1126/science.1203486
Cross-talk between myeloidderived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression, Semin. Cancer Biol, 2012. ,
Immunosurveillance in human non-viral cancers, Current Opinion in Immunology, vol.23, issue.2, pp.272-278, 2011. ,
DOI : 10.1016/j.coi.2010.12.011
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication, Immunological Reviews, vol.205, issue.1, pp.104-118, 2011. ,
DOI : 10.1111/j.1600-065X.2011.01007.x
A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1., Molecular Biology of the Cell, vol.7, issue.4, pp.565-577, 1996. ,
DOI : 10.1091/mbc.7.4.565
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium, Urologic Oncology: Seminars and Original Investigations, vol.22, issue.1, pp.3805-3811, 2003. ,
DOI : 10.1016/j.urolonc.2003.12.009
Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cells, Cancer Letters, vol.249, issue.2, pp.157-170, 2007. ,
DOI : 10.1016/j.canlet.2006.08.010
URL : https://hal.archives-ouvertes.fr/hal-00164921
Human Tumor Antigen MUC1 Is Chemotactic for Immature Dendritic Cells and Elicits Maturation but Does Not Promote Th1 Type Immunity, The Journal of Immunology, vol.175, issue.3 ,
DOI : 10.4049/jimmunol.175.3.1628
Overproduction of PGE2 in peripheral blood monocytes of gastrointestinal cancer patients with mucins in their bloodstream, Cancer Letters, vol.245, issue.1-2, pp.149-155, 2007. ,
DOI : 10.1016/j.canlet.2006.01.004
Different Progression of Tumor Xenografts between Mucin-Producing and Mucin-Non-Producing Mammary Adenocarcinoma-Bearing Mice, Cancer Research, vol.66, issue.12, pp.6175-6182, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-3663
Selectin ligands: will the real ones please stand up?, Journal of Clinical Investigation, vol.99, issue.2, pp.158-162, 1997. ,
DOI : 10.1172/JCI119142
sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis, Histol. Histopathol, vol.26, issue.10, pp.1305-1316, 2011. ,
Consequences of the expression of sialylated antigens in breast cancer, Carbohydrate Research, vol.345, issue.10, pp.1377-1383, 1994. ,
DOI : 10.1016/j.carres.2010.01.024
URL : https://hal.archives-ouvertes.fr/hal-00464837
Using monoclonal antibodies to stimulate antitumor cellular immunity, Expert Review of Vaccines, vol.10, issue.7, pp.1093-1106, 2011. ,
DOI : 10.1586/erv.11.33
Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma, Cancer, vol.97, issue.12, pp.2693-2702, 2000. ,
DOI : 10.1002/1097-0142(20000615)88:12<2693::AID-CNCR7>3.0.CO;2-3
Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma Xenografts, Cancer Research, vol.65, issue.14, pp.6425-6434, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0300
Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen, Clinical Cancer Research, vol.13, issue.18, pp.5613-5620, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-1057
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants., Proc. Natl Acad. Sci. USA. 91, pp.12957-12961, 1994. ,
DOI : 10.1073/pnas.91.26.12957
Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity, Clinical Cancer Research, vol.17, issue.5, pp.1024-1032, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-2640
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy, Clinical & Experimental Immunology, vol.99, issue.1, pp.206-215, 2012. ,
DOI : 10.1111/j.1365-2249.2011.04516.x
Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface, Cancer Immunology, Immunotherapy, vol.21, issue.12, pp.1789-1800, 2011. ,
DOI : 10.1007/s00262-011-1072-9
Targeting tumours with genetically enhanced T lymphocytes, Nature Reviews Cancer, vol.3, issue.1, pp.35-45, 2003. ,
DOI : 10.1038/nrc971
Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy, Expert Opinion on Biological Therapy, vol.2, issue.2, pp.855-873, 2011. ,
DOI : 10.1073/pnas.092562399
Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes, International Journal of Cancer, vol.96, issue.2, pp.228-236, 2001. ,
DOI : 10.1002/ijc.1457
Targeting of T Lymphocytes to Melanoma Cells Through Chimeric Anti-GD3 Immunoglobulin T-Cell Receptors, Neoplasia, vol.2, issue.5, pp.449-459, 2000. ,
DOI : 10.1038/sj.neo.7900108
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells, Clinical Cancer Research, vol.15, issue.18, pp.5852-5860, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-3163
Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor ?? Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors, Clinical Cancer Research, vol.16, issue.10, pp.2769-2780, 2010. ,
DOI : 10.1158/1078-0432.CCR-10-0043
Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice, Proc. Natl Acad. Sci. USA, pp.19051-19056, 2005. ,
DOI : 10.1073/pnas.0504312102
Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor, The Journal of Immunology, vol.180, issue.7, pp.4901-4909, 2008. ,
DOI : 10.4049/jimmunol.180.7.4901
CAR Mechanics: Driving T Cells into the MUC of Cancer, Cancer Research, vol.69, issue.11, pp.4559-4562, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0564
Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4, Journal of Biological Chemistry, vol.285, issue.33, pp.25538-25544, 2010. ,
DOI : 10.1074/jbc.M110.127951
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer, Journal of Biomedicine and Biotechnology, vol.21, issue.4 ,
DOI : 10.1038/nm.1882
Ganglioside conjugate vaccines Immunotherapy against tumors of neuroectodermal origin, Mol. Chem. Neuropathol, vol.2123, pp.299-309, 1994. ,
Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn, Cancer Immunology, Immunotherapy, vol.263, issue.5, pp.424-430, 2005. ,
DOI : 10.1007/s00262-004-0584-y
Immunogenicity of synthetic conjugates of Lewis y oligosaccharide with proteins in mice: towards the design of anticancer vaccines, Cancer Immunology, Immunotherapy, vol.45, issue.6, pp.281-286, 1998. ,
DOI : 10.1007/s002620050444
Recent development in carbohydrate-based cancer vaccines, Current Opinion in Chemical Biology, vol.13, issue.5-6, pp.5-6, 2009. ,
DOI : 10.1016/j.cbpa.2009.08.010
Induction of a Melanoma-Specific Antibody Response by a Monovalent, but not a Divalent, Synthetic GM2 Neoglycopeptide, ChemMedChem, vol.6, issue.4, pp.582-587, 2009. ,
DOI : 10.1002/cmdc.200900032
URL : https://hal.archives-ouvertes.fr/hal-00396633
Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate, Cancer Res, vol.50, issue.14, pp.4308-4314, 1990. ,
Chemoselective Assembly and Immunological Evaluation of Multiepitopic Glycoconjugates Bearing Clustered Tn Antigen as Synthetic Anticancer Vaccines, Bioconjugate Chemistry, vol.16, issue.5, pp.1149-1159, 2005. ,
DOI : 10.1021/bc050010v
Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice, Proc. Natl Acad. Sci. USA 98, pp.3264-3269, 2001. ,
DOI : 10.1073/pnas.051623598
Anti-Tumor Immunity Provided by a Synthetic Multiple Antigenic Glycopeptide Displaying a Tri-Tn Glycotope, The Journal of Immunology, vol.166, issue.4, pp.2849-2854, 2001. ,
DOI : 10.4049/jimmunol.166.4.2849
URL : https://hal.archives-ouvertes.fr/pasteur-00166855
A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates, Cancer Research, vol.64, issue.14, pp.4987-4994, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0252
URL : https://hal.archives-ouvertes.fr/pasteur-00166848
Immune Responses of Mice and Human Breast Cancer Patients following Immunization with Synthetic Sialyl-Tn Conjugated to KLH Plus Detox Adjuvant, Annals of the New York Academy of Sciences, vol.51, issue.1 Specific Immu, pp.276-291, 1993. ,
DOI : 10.1073/pnas.87.23.9498
Specificity of the IgG Response in Mice and Human Breast Cancer Patients Following Immunization Against Synthetic Sialyl-Tn, An Epitope with Possible Functional Significance in Metastasis, Adv. Exp. Med. Biol, vol.353, pp.105-124, 1994. ,
DOI : 10.1007/978-1-4615-2443-4_11
Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines, Vaccine, vol.20, issue.7-8, pp.1030-1038, 2002. ,
DOI : 10.1016/S0264-410X(01)00451-0
Synthetic carbohydrate vaccines: Synthesis and immunogenicity of Tn antigen conjugates, Bioorganic & Medicinal Chemistry, vol.2, issue.11, pp.1119-1132, 1994. ,
DOI : 10.1016/S0968-0896(00)82064-7
Sequential Immunization of Melanoma Patients with GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside, Clinical Cancer Research, vol.10, issue.14, pp.4717-4723, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0345
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant, Cancer Immunology Immunotherapy, vol.12, issue.4, pp.215-222, 1993. ,
DOI : 10.1007/BF01740902
Carbohydrate vaccines as immunotherapy for cancer, Immunology and Cell Biology, vol.22, issue.4, pp.418-428, 2005. ,
DOI : 10.1016/j.vaccine.2005.01.072
Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen, Journal of Peptide Research, vol.9, issue.2, pp.173-180, 2000. ,
DOI : 10.1023/A:1006939432665
URL : https://hal.archives-ouvertes.fr/pasteur-00166856
Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy, FEBS Letters, vol.412, issue.1, pp.24-28, 2000. ,
DOI : 10.1016/S0014-5793(00)01248-5
URL : https://hal.archives-ouvertes.fr/pasteur-00166863
Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation, Cancer Res, vol.58, issue.12, pp.2541-2549, 1998. ,
What Makes MUC1 a Tumor Antigen?, Tumor Biology, vol.155, issue.4, pp.217-220, 2005. ,
DOI : 10.1159/000070658
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides, Int. J. Cancer, vol.86, issue.5, pp.702-712, 2000. ,
Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses, Glycobiology, vol.15, issue.8, pp.735-746, 2005. ,
DOI : 10.1093/glycob/cwi058
Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice, Biological Chemistry, vol.390, issue.7, pp.611-618, 2009. ,
DOI : 10.1515/BC.2009.070
From Synthesis to Biologics: Preclinical Data on a Chemistry Derived Anticancer Vaccine, Journal of the American Chemical Society, vol.131, issue.26, pp.9298-9303, 2009. ,
DOI : 10.1021/ja901415s
Mucin-type O-glycosylation and its potential use in drug and vaccine development, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1780, issue.3, pp.546-563, 2008. ,
DOI : 10.1016/j.bbagen.2007.09.010
The nature and sequence of the amino acid aglycone strongly modulates the conformation and dynamics effects of Tn antigen's clusters future science group Review Freire & Osinaga 153 Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21, Chemistry Clin. Cancer Res, vol.15, issue.9, pp.3863-3874, 2003. ,
Synthesis and Immunological Properties of N-Modified GM3 Antigens as Therapeutic Cancer Vaccines, Journal of Medicinal Chemistry, vol.48, issue.3, pp.875-883, 2005. ,
DOI : 10.1021/jm0494422
The synthesis of 18??-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells, Bioorganic & Medicinal Chemistry, vol.15, issue.16, pp.5432-5439, 2007. ,
DOI : 10.1016/j.bmc.2007.05.057
Differential Antigen Processing by Dendritic Cell Subsets in Vivo, Science, vol.315, issue.5808, pp.107-111, 2007. ,
DOI : 10.1126/science.1136080
Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells, Immunity, vol.29, issue.3, pp.497-510, 2008. ,
DOI : 10.1016/j.immuni.2008.07.013
Signalling through C-type lectin receptors: shaping immune responses, Nature Reviews Immunology, vol.16, issue.7, pp.465-479, 2009. ,
DOI : 10.1038/nri2569
Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization, European Journal of Immunology, vol.223, issue.4, pp.916-925, 2011. ,
DOI : 10.1002/eji.201040762
Mannan Mucin-1 Peptide Immunization: Influence of Cyclophosphamide and the Route of Injection, Journal of Immunotherapy, vol.24, issue.2, pp.172-183, 2001. ,
DOI : 10.1097/00002371-200103000-00012
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy, Journal of Molecular Medicine, vol.75, issue.8, pp.594-602, 1997. ,
DOI : 10.1007/s001090050144
T/Tn Antigen Vaccine is Effective and Safe in Preventing Recurrence of Advanced Human Breast Carcinoma, Cancer Biotherapy, vol.9, issue.1, pp.7-15, 1994. ,
DOI : 10.1089/cbr.1994.9.7
Cancer vaccines: between the idea and the reality, Nature Reviews Immunology, vol.3, issue.8, pp.630-641, 2003. ,
DOI : 10.1038/nri1150
Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design, Biogerontology, vol.268, issue.1, pp.13-25, 2009. ,
DOI : 10.1007/s10522-008-9150-x
New gene therapy strategies for cancer treatment: a review of recent patents, Recent Pat. Anticancer Drug Discov, 2012. ,